ArticleCancer biology & therapy2026

Evaluating carboplatin and PARP inhibitor combination efficacy using high-grade serous carcinoma spheroids and organoids.

Emily J Tomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.